Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 3781
This examiner grants 35% of resolved cases
Quynh Dao Le is an examiner in Art Unit 3781, operating within Tech Center 3700. The data for this examiner includes 46 resolved cases, providing a focused look at their prosecution tendencies. The current allowance rate is 34.8 percent, which suggests a rigorous examination environment where less than half of the applications reach issuance. Practitioners should note the interview lift of 10.1 percent, which indicates that personal communication with the examiner provides a measurable benefit in securing an allowance.
The median days to allowance for this examiner is 1281, representing a relatively long prosecution timeline of over three and a half years. This 1281-day figure is a critical metric for applicants to consider when planning their patent strategy and budgeting for long-term prosecution. The 34.8 percent allowance rate, coupled with the 10.1 percent lift, suggests that while the path to allowance is challenging, interviews remain a viable tool for advancing a case. With 46 resolved cases, the examiner's patterns are established but may still evolve. Practitioners should prepare for a detailed and potentially extended examination process in Art Unit 3781. The 1281-day median pendency remains the primary benchmark for timeline expectations.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19036503 | PACKAGES OF FOLDED ABSORBENT ARTICLES AND FOLDED ABSORBENT ARTICLES | Non-Final OA | The Procter & Gamble Company |
| 18815143 | DURABLE ABSORBENT PANT | Final Rejection | The Procter & Gamble Company |
| 17520456 | OCULAR IMPLANT WITH PRESSURE SENSOR AND DELIVERY SYSTEM | Final Rejection | Alcon Inc.. |
| 17503188 | TRANSCAVAL VENTURI | Non-Final OA | Edwards Lifesciences Corporation |
| 18989242 | SMART PROGRAMMABLE BLOOD PUMP FOR CONTROLLING AND AUTOMATING EXTRACORPOREAL LIFE SUPPORT APPLICATIONS | Non-Final OA | VANDERBILT UNIVERSITY |
| 18104750 | SYSTEMS AND METHODS FOR AUTOMATIC BIDIRECTIONAL PRIMING OF A GAS-ENRICHMENT SYSTEM | Non-Final OA | Zoll Circulation, Inc. |
| 17783359 | APPARATUS AND METHOD FOR USE OF FLUID FLOW DEVICE | Final Rejection | THE CLEVELAND CLINIC FOUNDATION |
| 18547969 | PHOTO-ECMO APPARATUS, SYSTEMS, AND METHODS | Non-Final OA | The General Hospital Corporation |
| 18855709 | Automated Syringe | Non-Final OA | Becton, Dickinson and Company |
| 18885880 | Closed-System Infusion Adapter with Simplified Connection Mechanism | Non-Final OA | Becton, Dickinson and Company |
| 17791321 | Vial Adapter Device | Final Rejection | Becton, Dickinson and Company |
| 18504509 | METHODS, APPARATUSES, AND SYSTEMS FOR ASPIRATING AIRWAYS | Final Rejection | Board of Regents, The University of Texas System |
| 17731984 | SYSTEM FOR PERSONALIZED SKIN TREATMENT INCLUDING DISPENSER AND CARTRIDGE-BASED APPLICATOR | Final Rejection | L'Oreal |
| 19039888 | HEART-LUNG MACHINE WITH SEMI-AUTONOMOUS INITIATION MODE | Non-Final OA | Terumo Cardiovascular Systems Corporation |
| 19022706 | WASHABLE AND REUSABLE ABSORBENT UNDERGARMENT | Non-Final OA | Essity Hygiene and Health Aktiebolag |
| 17948738 | RESPIRATORY ASSIST AND FLUID REMOVAL DEVICE FOR TREATMENT OF RESPIRATORY DISTRESS SYNDROME | Final Rejection | THE CHARLES STARK DRAPER LABORATORY, INC. |
| 17635029 | METHOD FOR PRIMING AN EXTRACORPOREAL BLOOD CIRCUIT OF AN APPARATUS FOR EXTRACORPOREAL TREATMENT OF BLOOD AND APPARATUS FOR EXTRACORPOREAL TREATMENT OF BLOOD | Non-Final OA | GAMBRO LUNDIA AB |
| 17634855 | NON-REMOVABLE CONNECTION SYSTEM | Final Rejection | GAMBRO LUNDIA AB |
| 18920829 | THERAPEUTIC PLASMA EXCHANGE METHODS AND APHERESIS KIT FOR FLUSH AND DIVERT PRIME STAGE WHEN USING AN ADSORPTION COLUMN | Non-Final OA | Fenwal, Inc. |
| 17686122 | DUAL LUMEN DRAINAGE CANNULA WITH SINGLE OUTLET | Non-Final OA | CardiacAssist, Inc. |
| 18455006 | DIALYSIS APPARATUS AND METHOD FOR CHECKING CONNECTION OF REPLENISHER PASSAGE | Final Rejection | SHIBUYA CORPORATION |
| 18277959 | LOCO-REGIONAL PERFUSION OF AN UNARRESTED BEATING HEART | Final Rejection | DiNAQOR AG |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy